AzTrials
AzTrials

StrokeNAVISTROKENCT03956160

Development and Evaluation of a Patient-centered Transition Program for Stroke Patients, Combining Case Management and Access to an Internet Information Platform

A study testing A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation. in people with Stroke, run by Hospices Civils de Lyon.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Due to the brutality of stroke and increasingly shorter lengths of hospital stay, patients and their families must adapt quickly to the patient's new state of health and the new role of caregiver for family members. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
No sites listed yet
Study dates
30 Dec 2021to 30 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient,
  • Having had a first confirmed, ischemic or hemorrhagic stroke
  • Managed in the participating stroke center
  • Whose return home directly from the stroke center is planned
  • Presenting a modified Rankin score of 1 to 3 when deciding to leave the stroke center
  • Having given its written consent
  • Whose main residence is located in the Rhône department of France
  • Aphasic patients may be included if a caregiver can follow up with the case manager

Who cannot join

  • Patient residing in an institution prior to stroke
  • Supported in the gerontological field before stroke
  • Inability to communicate by telephone with the case-manager and absence of a caregiver to follow up by telephone with the case-manager

Trial locations and contacts

No sites are listed yet.

About this study

Due to the brutality of stroke and increasingly shorter lengths of hospital stay, patients and their families must adapt quickly to the patient's new state of health and the new role of caregiver for family members. Patients and caregivers report a significant need for advice and information during this transition period. Thus, the provision of information through an Internet platform could meet these characteristics, in association with individualised support by a case-manager to ensure continuity of care and improve care pathway.

The investigating team's hypothesis is that, through comprehensive, individualized and flexible support for patients and their caregivers, a patient-centred post-stroke hospital/home transition program, combining an Internet platform and telephone follow-up by a case-manager, could improve patients' level of participation and quality of life.

Read the detailed description

Going back home following a stroke is a key step for the patient and his or her relatives. Due to the brutality of stroke and increasingly shorter lengths of hospital stay, patients and their families must adapt quickly to the patient's new state of health and the new role of caregiver for family members. Currently, 70% of patients return home directly after treatment in a stroke center. Following the acute phase, the patient's care path involves many health and social workers. However, the health care system is complex and difficult for patients and their caregivers to understand. A lack of support during the hospital/home transition has significant negative consequences for the patient (reduced functional prognosis, quality of life and reintegration, increased risk of recurrence) and his or her caregiver (increased perceived burden, decreased quality of life, socio-economic impact).

Patients and caregivers report a significant need for advice and information during this transition period. They are looking for individualized, good quality information and whose nature evolves over time with the needs and recovery of the patient. Thus, the provision of information through an Internet platform could meet these characteristics, in association with individualised support by a case-manager to ensure continuity of care and improve care pathway. In France, no such program has been developed to date for stroke. Existing transition programmes mainly focus on home rehabilitation and do not offer a comprehensive approach to the situation, integrating caregivers. In addition, no programs have been developed in partnership with patients and families to best meet their needs.

The investigator's hypothesis is that, through comprehensive, individualized and flexible support for patients and their caregivers, a patient-centred post-stroke hospital/home transition program, combining an Internet platform and telephone follow-up by a case-manager, could improve patients' level of participation and quality of life.

Conditions
Stroke
Being tested
A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation.
Keywords
Caregiver, Support
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation.Other

    4 participatory co-design workshops lasting 4 hours each that will follow a "user-centered design" approach: identification of end-user needs, prototyping/development of the intervention (case-management procedures and platform), iterative improvement, end-user testing.

    Based on the cognitive social theory underpinning the intervention, scientific literature, an overview of existing organizations and the results of the Stroke 69 and Arthur Tybra studies (patient needs following the acute phase), the advisory committee will:

    • Define the case-manager's profile, and required knowledge and skills
    • Identify the resources and tools to be proposed on the Internet platform
    • Test the tools and content
    • Refine the program evaluation criteria
    • Test and validate the study procedures.
Study groups in NCT03956160
Study groupRoleWhat they receive
Intervention groupExperimentalFor 12 months from the return home, patients in the intervention group will benefit from telephone support by a trained case-manager (number and frequency of contacts defined according to the patient's needs) and access to an Internet platform. The intervention aims to improve the patient's ability to manage his or her situation and meet his or her needs upon return home, including identifying and requesting the necessary health or social resources.
Receives: Other: A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation.
Control groupNo interventionPatients randomized to the control group will receive the usual practices. As part of the study, they will be contacted for data collection upon their return home, at 6 months and 12 months by a clinical research associate. Access to the internet platform and an interview with the case-manager will be offered at the end of the study to patients in the control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participation at 6 months after hospital discharge

    Patient participation score, measured by the score obtained in the "participation" dimension of the stroke-specific quality of life scale: Stroke Impact Scale 6 months after discharge from hospital

    Measured: 6 months

Secondary outcomes (32)
  1. Participation at 12 months

    Participation score at 12 months after discharged home

    Measured: 12 months

  2. Quality of life at 6 months after hospital discharge: Stroke Impact Scale (SIS)

    Score of the other dimensions of the Stroke Impact Scale (SIS) at 6 months: force dimension, manual function, daily activities, mobility, communication, emotions, memory/thinking and global recovery.

    Measured: 6 months

  3. Quality of life at 12 months after hospital discharge: Stroke Impact Scale (SIS)

    Score of the other dimensions of the Stroke Impact Scale (SIS) at 12 months: force dimension, manual function, daily activities, mobility, communication, emotions, memory/thinking and global recovery.

    Measured: 12 months

  4. Anxiety and depression scores at 6 months after hospital discharge

    Change of anxiety and depression scores between discharge home and 6 months measured by the Hospital Anxiety and Depression scale (HADS) score.

    Measured: 6 months

  5. Anxiety and depression scores at 12 months after hospital discharge

    Change of anxiety and depression scores between discharge home and 12 months measured by the Hospital Anxiety and Depression scale (HADS) score.

    Measured: 12 months

  6. Fatigue at 6 months after hospital discharge

    Changes in fatigue level measured by the Pichot scale between discharge home and 6 months

    Measured: 6 months

  7. Fatigue at 12 months after hospital discharge

    Changes in fatigue level measured by the Pichot scale between discharge home and 12 months

    Measured: 12 months

  8. Sleep quality at 6 months after hospital discharge: Pittsburgh scale

    Sleep quality measured by the Pittsburgh scale between discharge home and 6 months

    Measured: 6 months

  9. Sleep quality at 12 months after hospital discharge: Pittsburgh scale

    Sleep quality measured by the Pittsburgh scale between discharge home and 12 months

    Measured: 12 months

  10. Sleepiness at 6 months after hospital discharge

    Sleepiness level measured by the Epworth scale between discharge home and 6 months

    Measured: 6 months

  11. Sleepiness at 12 months after hospital discharge

    Sleepiness level measured by the Epworth scale between discharge home and 12 months

    Measured: 12 months

  12. Prognosis at 12 months after hospital discharge (Stroke recurrence)

    Stroke recurrence within 12 months, reported by the patient and/or caregiver and validated by checking the hospitalization report.

    Measured: 12 months

  13. Prognosis at 12 months after hospital discharge (hospitalizations)

    Unscheduled hospitalizations or emergency room visits within 12 months of discharge from hospital.

    Measured: 12 months

  14. Prognosis at 12 months after hospital discharge (neurologic disability)

    Modified Rankin Score at 12-month

    Measured: 12 months

  15. Prognosis at 12 months after hospital discharge (death)

    Death at 12 months

    Measured: 12 months

  16. Cognitive disorders at hospital discharge

    Cognitive disorders at discharge from hospital measured by the Montreal Cognitive Assessment (MOCA) scale

    Measured: 1 day

  17. Cognitive disorders at 12 months after hospital discharge

    Cognitive disorders at 12 months measured by the Montreal Cognitive Assessment (MOCA) scale

    Measured: 12 months

  18. Access to care at 12 months after hospital discharge

    Consumption of care (consultations and hospitalizations) collected from the regional health insurance database

    Measured: 12 months

  19. Access to social services at 12 months after hospital discharge

    Requests for social support made

    Measured: 12 months

  20. Maintaining hospital discharge prescriptions at 6 months after hospital discharge

    Therapeutic persistence: maintenance of therapeutic prescriptions for discharge from hospital at 6 months. The prescriptions for secondary preventive treatment of stroke will be considered. Data will be collected by interviewing the patient.

    Measured: 6 months

  21. Maintaining hospital discharge prescriptions at 12 months after hospital discharge

    Therapeutic persistence: maintenance of therapeutic prescriptions for discharge from hospital at 12 months. The prescriptions for secondary preventive treatment of stroke will be considered. Data will be collected by interviewing the patient.

    Measured: 12 months

  22. Occupational status at 12 months after hospital discharge

    Occupational status at 12 months: return to work will be defined by working at least one day per week. Among these patients, resumption of the same professional activity, professional reclassification or adapted working time, early retirement.

    Measured: 12 months

  23. Social isolation at discharge from hospital

    Social isolation at discharge from hospital measured by the Social Support score Questionnaire 6

    Measured: 1 day

  24. Social isolation at 6 months after hospital discharge

    Social isolation at 6 months after discharge from hospital measured by the Social Support score

    Measured: 6 months

  25. Social isolation at 12 months after hospital discharge

    Social isolation at 12 months after discharge from hospital measured by the Social Support score

    Measured: 12 months

  26. Patient activation level at discharge from hospital

    Patient activation will be measured by the score obtained at the "Patient activation Measure" scale. This questionnaire is composed of 22 items that assess the patient's knowledge, skills and confidence level to manage their own situation (self-management).

    Measured: 1 day

  27. Patient activation level at 6 months after hospital discharge

    Patient activation will be measured by the score obtained at the "Patient activation Measure" scale. This questionnaire is composed of 22 items that assess the patient's knowledge, skills and confidence level to manage their own situation (self-management).

    Measured: 6 months

  28. Patient activation level at 12 months after hospital discharge

    Patient activation will be measured by the score obtained at the "Patient activation Measure" scale. This questionnaire is composed of 22 items that assess the patient's knowledge, skills and confidence level to manage their own situation (self-management).

    Measured: 12 months

  29. Maintenance at home at 12 months after hospital discharge

    Data concerning the patient's place of residence 12 months after hospital discharge will be collected by interviewing the patient

    Measured: 12 months

  30. Satisfaction with the support received upon return home: ad-hoc questionnaire

    Satisfaction with the support received upon return home, measured at 12 months by an ad-hoc questionnaire

    Measured: 12 months

  31. Feeling towards information at 6 months after hospital discharge: ad-hoc questionnaire

    Feeling of information about stroke and medical and social care at 6 months through an ad-hoc questionnaire

    Measured: 6 months

  32. Feeling towards information at 12 months after hospital discharge: ad-hoc questionnaire

    Feeling of information about stroke and medical and social care at 12 months through an ad-hoc questionnaire

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2019
  2. Study start30 Dec 2021 (estimated)
  3. Primary completion31 Mar 2022 (estimated)
  4. Study completion30 Sep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03956160
Sponsor's protocol ID
69HCL19_0042
Acronym
NAVISTROKE
Status last verified
Sep 2021
First submitted
15 May 2019
Last updated
17 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures and appendices) may be shared with researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

Publications

  • Termoz A, Delvallee M, Damiolini E, Marchal M, Preau M, Huchon L, Mazza S, Habchi O, Bravant E, Derex L, Nighoghossian N, Cakmak S, Rabilloud M, Denis A, Schott AM, Haesebaert J. Co-design and evaluation of a patient-centred transition programme for stroke patients, combining case management and access to an internet information platform: study protocol for a randomized controlled trial - NAVISTROKE. BMC Health Serv Res. 2022 Apr 22;22(1):537. doi: 10.1186/s12913-022-07907-5.

    PubMed 35459183

Questions about this trial

What is this clinical trial studying?

A study testing A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation. in people with Stroke, run by Hospices Civils de Lyon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Julie Haesebaert, Dr (4 72 68 49 05 ext. 33, julie.haesebaert01@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participation at 6 months after hospital discharge (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03956160, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in